Nuclear Factor κB and Anesthetic Preconditioning during Myocardial Ischemia-Reperfusion

Caiyun Zhong, Yamei Zhou, Hong Liu

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background: Volatile anesthetic preconditioning (APC) protects against myocardial ischemia-reperfusion (IR) injury, but the precise mechanisms underlying this phenomenon remain undefined. To investigate the molecular mechanism of APC in myocardial protection, the activation of nuclear factor (NF) κB and its regulated inflammatory mediators expression were examined in the current study. Methods: Hearts from male rats were isolated, Langendorff perfused, and randomly assigned to one of three groups: (1) the control group: hearts were continuously perfused for 130 min; (2) the IR group: 30 min of equilibration, 15 min of baseline, 25 min of ischemia, 60 min of reperfusion; and (3) the APC + IR group: 30 min of equilibration, 10 min of sevoflurane exposure and a 5-min washout, 25 min of global ischemia, 60 min of reperfusion. Tissue samples were acquired at the end of reperfusion. NF-κB activity was determined by electrophoretic mobility shift assay. The NF-κB inhibitor, IκB-α, was determined by Western blot analysis. Myocardial inflammatory mediators, including tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase, were also assessed by Western blot analysis. Results: Nuclear factor κB-DNA binding activity was significantly increased at the end of reperfusion in rat myocardium, and cytosolic IκB-α was decreased. Supershift assay revealed the involvement of NF-κB p65 and p50 subunits. APC with sevoflurane attenuated NF-κB activation and reduced the expression of tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase. APC also reduced infarct size and creatine kinase release and improved myocardial left ventricular developed pressure during IR. Conclusions: The results of this study indicate that attenuation of NF-κB activation and subsequent down-regulation of NF-κB-dependent inflammatory gene expression plays an important role in the protective mechanism of APC against acute myocardial IR injury.

Original languageEnglish (US)
Pages (from-to)540-546
Number of pages7
JournalAnesthesiology
Volume100
Issue number3
DOIs
StatePublished - Mar 2004

Fingerprint

Myocardial Reperfusion
Reperfusion
Myocardial Ischemia
Anesthetics
Ischemia
Myocardial Reperfusion Injury
Nitric Oxide Synthase Type II
Intercellular Adhesion Molecule-1
Reperfusion Injury
Interleukin-1
Myocardial Ischemic Preconditioning
Tumor Necrosis Factor-alpha
Western Blotting
B-Form DNA
Electrophoretic Mobility Shift Assay
Ventricular Pressure
Creatine Kinase
Myocardium
Down-Regulation
Gene Expression

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Nuclear Factor κB and Anesthetic Preconditioning during Myocardial Ischemia-Reperfusion. / Zhong, Caiyun; Zhou, Yamei; Liu, Hong.

In: Anesthesiology, Vol. 100, No. 3, 03.2004, p. 540-546.

Research output: Contribution to journalArticle

@article{79fe09c881d646c2be38e4a1a879aeb6,
title = "Nuclear Factor κB and Anesthetic Preconditioning during Myocardial Ischemia-Reperfusion",
abstract = "Background: Volatile anesthetic preconditioning (APC) protects against myocardial ischemia-reperfusion (IR) injury, but the precise mechanisms underlying this phenomenon remain undefined. To investigate the molecular mechanism of APC in myocardial protection, the activation of nuclear factor (NF) κB and its regulated inflammatory mediators expression were examined in the current study. Methods: Hearts from male rats were isolated, Langendorff perfused, and randomly assigned to one of three groups: (1) the control group: hearts were continuously perfused for 130 min; (2) the IR group: 30 min of equilibration, 15 min of baseline, 25 min of ischemia, 60 min of reperfusion; and (3) the APC + IR group: 30 min of equilibration, 10 min of sevoflurane exposure and a 5-min washout, 25 min of global ischemia, 60 min of reperfusion. Tissue samples were acquired at the end of reperfusion. NF-κB activity was determined by electrophoretic mobility shift assay. The NF-κB inhibitor, IκB-α, was determined by Western blot analysis. Myocardial inflammatory mediators, including tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase, were also assessed by Western blot analysis. Results: Nuclear factor κB-DNA binding activity was significantly increased at the end of reperfusion in rat myocardium, and cytosolic IκB-α was decreased. Supershift assay revealed the involvement of NF-κB p65 and p50 subunits. APC with sevoflurane attenuated NF-κB activation and reduced the expression of tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase. APC also reduced infarct size and creatine kinase release and improved myocardial left ventricular developed pressure during IR. Conclusions: The results of this study indicate that attenuation of NF-κB activation and subsequent down-regulation of NF-κB-dependent inflammatory gene expression plays an important role in the protective mechanism of APC against acute myocardial IR injury.",
author = "Caiyun Zhong and Yamei Zhou and Hong Liu",
year = "2004",
month = "3",
doi = "10.1097/00000542-200403000-00012",
language = "English (US)",
volume = "100",
pages = "540--546",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Nuclear Factor κB and Anesthetic Preconditioning during Myocardial Ischemia-Reperfusion

AU - Zhong, Caiyun

AU - Zhou, Yamei

AU - Liu, Hong

PY - 2004/3

Y1 - 2004/3

N2 - Background: Volatile anesthetic preconditioning (APC) protects against myocardial ischemia-reperfusion (IR) injury, but the precise mechanisms underlying this phenomenon remain undefined. To investigate the molecular mechanism of APC in myocardial protection, the activation of nuclear factor (NF) κB and its regulated inflammatory mediators expression were examined in the current study. Methods: Hearts from male rats were isolated, Langendorff perfused, and randomly assigned to one of three groups: (1) the control group: hearts were continuously perfused for 130 min; (2) the IR group: 30 min of equilibration, 15 min of baseline, 25 min of ischemia, 60 min of reperfusion; and (3) the APC + IR group: 30 min of equilibration, 10 min of sevoflurane exposure and a 5-min washout, 25 min of global ischemia, 60 min of reperfusion. Tissue samples were acquired at the end of reperfusion. NF-κB activity was determined by electrophoretic mobility shift assay. The NF-κB inhibitor, IκB-α, was determined by Western blot analysis. Myocardial inflammatory mediators, including tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase, were also assessed by Western blot analysis. Results: Nuclear factor κB-DNA binding activity was significantly increased at the end of reperfusion in rat myocardium, and cytosolic IκB-α was decreased. Supershift assay revealed the involvement of NF-κB p65 and p50 subunits. APC with sevoflurane attenuated NF-κB activation and reduced the expression of tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase. APC also reduced infarct size and creatine kinase release and improved myocardial left ventricular developed pressure during IR. Conclusions: The results of this study indicate that attenuation of NF-κB activation and subsequent down-regulation of NF-κB-dependent inflammatory gene expression plays an important role in the protective mechanism of APC against acute myocardial IR injury.

AB - Background: Volatile anesthetic preconditioning (APC) protects against myocardial ischemia-reperfusion (IR) injury, but the precise mechanisms underlying this phenomenon remain undefined. To investigate the molecular mechanism of APC in myocardial protection, the activation of nuclear factor (NF) κB and its regulated inflammatory mediators expression were examined in the current study. Methods: Hearts from male rats were isolated, Langendorff perfused, and randomly assigned to one of three groups: (1) the control group: hearts were continuously perfused for 130 min; (2) the IR group: 30 min of equilibration, 15 min of baseline, 25 min of ischemia, 60 min of reperfusion; and (3) the APC + IR group: 30 min of equilibration, 10 min of sevoflurane exposure and a 5-min washout, 25 min of global ischemia, 60 min of reperfusion. Tissue samples were acquired at the end of reperfusion. NF-κB activity was determined by electrophoretic mobility shift assay. The NF-κB inhibitor, IκB-α, was determined by Western blot analysis. Myocardial inflammatory mediators, including tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase, were also assessed by Western blot analysis. Results: Nuclear factor κB-DNA binding activity was significantly increased at the end of reperfusion in rat myocardium, and cytosolic IκB-α was decreased. Supershift assay revealed the involvement of NF-κB p65 and p50 subunits. APC with sevoflurane attenuated NF-κB activation and reduced the expression of tumor necrosis factor α, interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase. APC also reduced infarct size and creatine kinase release and improved myocardial left ventricular developed pressure during IR. Conclusions: The results of this study indicate that attenuation of NF-κB activation and subsequent down-regulation of NF-κB-dependent inflammatory gene expression plays an important role in the protective mechanism of APC against acute myocardial IR injury.

UR - http://www.scopus.com/inward/record.url?scp=1442308454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442308454&partnerID=8YFLogxK

U2 - 10.1097/00000542-200403000-00012

DO - 10.1097/00000542-200403000-00012

M3 - Article

C2 - 15108966

AN - SCOPUS:1442308454

VL - 100

SP - 540

EP - 546

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 3

ER -